SARASOTA, FL, UNITED STATES, January 28, 2026 / EINPresswire.com / — Identifyn ®, a leader in super-resolution applications ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...

Quest expects the new blood test will support response monitoring in clinical trials.

Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Swift Analytical Ltd, based at York Science Park, has facilitated the first UK installation of the CytoStellar spectral flow cytometer.

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...

Explore how biochemistry, microbiology, and pathology collaborate in cancer care for early detection, personalized treatment, and survival monitoring.

Nonresponse to bridging therapy and high lymphocyte count were predictive of parkinsonism and nonrelapse mortality (NRM) after treatment with ciltacabtagene autoleucel (cilta-cel; Carvykti) in ...

Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

Extracellular vesicles can provide a wealth of information, but these intriguing messengers are notoriously difficult to detect. This could be about to change. Extracellular vesicles (EVs) are a ...

Efficient separation of microalgae is essential for biotechnology, food science, and sustainable bio-production, yet ...

Artificial intelligence (AI) is now an essential tool in biopharma manufacturing, yet industry still needs guidelines on how LLMs, ML, and other technologies should be used in drug making, say the ...